课题基金 / 基金详情

Gut flora and synbiotics therapy in patients with severe SIRS

Gut flora and synbiotics therapy in patients with severe SIRS
严重 SIRS 患者的肠道菌群和合生元治疗
批准号:
17591887
负责人:
SHIMIZU Kentaro
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

SHIMIZU Kentaro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The gut is considered an important target organ of injury following severe insult such as sepsis, trauma, and shock. Synbiotics therapy is a combination with probiotics and prebiotics. We quantitatively evaluated changes in the gut microflora and environment in patients with severe SIRS, examined the effects of synbiotic treatment on clinical course, and evaluated the limitation of synbiotic treatment on gut dysmotility.1) The gut flora and environment are significantly altered in patients with severe SIRS. Analysis of fecal flora confirmed that patients with severe SIRS showed significantly lower total anaerobic bacterial counts, in particular, 2-4 log units fewer beneficial Bifidobacterium and Lactobacillus and 2 log units more pathogenic Staphylococcus and Pseudomonas group counts than did healthy volunteers. Concentrations of total fecal organic acids, in particular, beneficial short-chain fatty acids such as acetic acid, propionic acid, and butyric acid, were significantly decreas … More ed in the patients.2) Synbiotics maintain the gut flora and environment in patients with severe SIRS and significantly reduce the incidence of septic complications. The incidences of infectious complications in patients with severe SIRS were significantly lower in the synbiotics group than in the control group(enteritis, 7%vs. 46%, pneumonia, 20% vs. 52%,and bacteremia, 10%vs. 33%, respectively). These beneficial effects of synbiotics in the present study may be due to improved gut flora, increased short-chain fatty acids.3) In SIRS patients with synbiotic therapy(50cases), intestinal dymotility patients(5 cases) all had deterioration in their gut flora, caused bacteremia, and were mortal.As a result, the deterioration of gut flora were related with septic complications and mortality. Synbiotics could maintain the gut flora and protect the critically ill patients from infectious complications. Further study is needed to clarify the mechanisms by which synbiotics decrease septic complications in patients with SIRS. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIRS患者における腸内細菌叢、腸内環境の変化とシンバイオティクス療法の有効性
SIRS 患者的肠道菌群、肠道环境变化以及合生元治疗的有效性
DOI: --
发表时间: 2006
期刊: 日本救急医学会雑誌 17巻12号
影响因子: --
作者: [清水健太郎, 小倉裕司, 後藤美紀, 朝原崇, 野本康二, 諸富正己, 平出敦, 松嶋麻子, 田崎修, 鍬方安行, 田中裕, 嶋津岳士, 杉本壽]
通讯作者: 杉本壽
熱傷患者の腸内細菌叢の変化と臨床経過〜3例の報告
烧伤患者肠道菌群变化及临床病程3例报告
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagala Y, Tanaka H, Shimazu T, Sugimoto H., 清水健太郎, 清水 健太郎, 清水健太郎, 清水健太郎, 清水健太郎, 清水健太郎, 清水健太郎]
通讯作者: 清水健太郎
SIRS患者における腸内細菌叢および腸内環境の崩壊とシンバイオティクス治療の効果
SIRS患者肠道菌群和肠道环境的破坏及合生元治疗的效果
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Shimizu K. Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Tasaki O, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H, 清水健太郎]
通讯作者: 清水健太郎
Intestinal dysmotility and enteritis increase septic mortality in patients with severe SIRS
肠动力障碍和肠炎会增加严重 SIRS 患者的败血症死亡率
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagala Y, Tanaka H, Shimazu T, Sugimoto H., 清水健太郎, 清水 健太郎, 清水健太郎, 清水健太郎, 清水健太郎, 清水健太郎, 清水健太郎, 清水健太郎]
通讯作者: 清水健太郎
22
    Development of protein-carbohydrate binding prediction systems and databases
    • 批准号:
      23300109
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2011
    • 负责人:
      SHIMIZU Kentaro
    • 依托单位:
    Database Development and Functional Analysis of Protein Disorder Regions
    • 批准号:
      20500269
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      SHIMIZU Kentaro
    • 依托单位:
    Development of methods for high-resolution protein structure modeling and for model structure assessment
    • 批准号:
      17500191
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.34万
    • 财政年份:
      2005
    • 负责人:
      SHIMIZU Kentaro
    • 依托单位:
    Development of a Parallel Programming Environment based on Distributed Shared Arrays with Application-Specific Resource Management
    • 批准号:
      13680396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.62万
    • 财政年份:
      2001
    • 负责人:
      SHIMIZU Kentaro
    • 依托单位:
    海外基金